These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23762301)

  • 41. Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside.
    Castella B; Vitale C; Coscia M; Massaia M
    Cell Mol Life Sci; 2011 Jul; 68(14):2419-32. PubMed ID: 21584812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL.
    Darcy PK; Haynes NM; Snook MB; Trapani JA; Cerruti L; Jane SM; Smyth MJ
    J Immunol; 2000 Apr; 164(7):3705-12. PubMed ID: 10725729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphoantigen-expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses.
    Qin G; Mao H; Zheng J; Sia SF; Liu Y; Chan PL; Lam KT; Peiris JS; Lau YL; Tu W
    J Infect Dis; 2009 Sep; 200(6):858-65. PubMed ID: 19656068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signaling.
    Ravi R; Fuchs EJ; Jain A; Pham V; Yoshimura K; Prouser T; Jalla S; Zhou X; Garrett-Mayer E; Kaufmann SH; Schulick RD; Pardoll DM; Bedi A
    Cancer Res; 2006 Feb; 66(3):1730-9. PubMed ID: 16452233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tim-3 suppresses the killing effect of Vγ9Vδ2 T cells on colon cancer cells by reducing perforin and granzyme B expression.
    Li X; Lu H; Gu Y; Zhang X; Zhang G; Shi T; Chen W
    Exp Cell Res; 2020 Jan; 386(1):111719. PubMed ID: 31726050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AW00179 potentiates TRAIL-mediated death of human lung cancer H1299 cells through ROS-JNK-c-Jun-mediated up-regulation of DR5 and down-regulation of anti-apoptotic molecules.
    Hwang MK; Ryu BJ; Kim SH
    Amino Acids; 2012 Oct; 43(4):1679-87. PubMed ID: 22354145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy.
    Du SH; Li Z; Chen C; Tan WK; Chi Z; Kwang TW; Xu XH; Wang S
    PLoS One; 2016; 11(9):e0161820. PubMed ID: 27598655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells.
    Morita R; Nishizawa S; Torigoe T; Takahashi A; Tamura Y; Tsukahara T; Kanaseki T; Sokolovskaya A; Kochin V; Kondo T; Hashino S; Asaka M; Hara I; Hirohashi Y; Sato N
    Cancer Sci; 2014 Apr; 105(4):389-95. PubMed ID: 24450541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. BET Inhibitors Potentiate Chemotherapy and Killing of
    Tan X; Tong J; Wang YJ; Fletcher R; Schoen RE; Yu J; Shen L; Zhang L
    Cancer Res; 2019 Mar; 79(6):1191-1203. PubMed ID: 30674532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells.
    Inoda S; Hirohashi Y; Torigoe T; Morita R; Takahashi A; Asanuma H; Nakatsugawa M; Nishizawa S; Tamura Y; Tsuruma T; Terui T; Kondo T; Ishitani K; Hasegawa T; Hirata K; Sato N
    Am J Pathol; 2011 Apr; 178(4):1805-13. PubMed ID: 21435460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to V alpha 24+ NKT cell-mediated cytotoxicity.
    Mattarollo SR; Kenna T; Nieda M; Nicol AJ
    Int J Cancer; 2006 Oct; 119(7):1630-7. PubMed ID: 16646079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects.
    Yu R; Deedigan L; Albarenque SM; Mohr A; Zwacka RM
    Cell Death Dis; 2013 Feb; 4(2):e503. PubMed ID: 23429289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of ATF3 in synergistic cancer cell killing by a combination of HDAC inhibitors and agonistic anti-DR5 antibody through ER stress in human colon cancer cells.
    Liu J; Edagawa M; Goshima H; Inoue M; Yagita H; Liu Z; Kitajima S
    Biochem Biophys Res Commun; 2014 Mar; 445(2):320-6. PubMed ID: 24530917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.
    Hoeres T; Smetak M; Pretscher D; Wilhelm M
    Front Immunol; 2018; 9():800. PubMed ID: 29725332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chitosan Nanoparticles Strengthen Vγ9Vδ2 T-Cell Cytotoxicity Through Upregulation Of Killing Molecules And Cytoskeleton Polarization.
    Lin L; He J; Li J; Xu Y; Li J; Wu Y
    Int J Nanomedicine; 2019; 14():9325-9336. PubMed ID: 31819434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination doxorubicin and interferon-α therapy stimulates immunogenicity of murine pancreatic cancer Panc02 cells via up-regulation of NKG2D ligands and MHC class I.
    Wang WJ; Qin SH; Zhang JW; Jiang YY; Zhang JN; Zhao L
    Asian Pac J Cancer Prev; 2014; 15(22):9667-72. PubMed ID: 25520086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD11c+ dendritic cells and B cells contribute to the tumoricidal activity of anti-DR5 antibody therapy in established tumors.
    Haynes NM; Hawkins ED; Li M; McLaughlin NM; Hämmerling GJ; Schwendener R; Winoto A; Wensky A; Yagita H; Takeda K; Kershaw MH; Darcy PK; Smyth MJ
    J Immunol; 2010 Jul; 185(1):532-41. PubMed ID: 20505139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies.
    Fan CW; Chen T; Shang YN; Gu YZ; Zhang SL; Lu R; OuYang SR; Zhou X; Li Y; Meng WT; Hu JK; Lu Y; Sun XF; Bu H; Zhou ZG; Mo XM
    Cell Death Dis; 2013 Oct; 4(10):e828. PubMed ID: 24091671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma Cells.
    Chauvin C; Joalland N; Perroteau J; Jarry U; Lafrance L; Willem C; Retière C; Oliver L; Gratas C; Gautreau-Rolland L; Saulquin X; Vallette FM; Vié H; Scotet E; Pecqueur C
    Clin Cancer Res; 2019 Dec; 25(23):7218-7228. PubMed ID: 31506386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A WKYMVm-containing combination elicits potent anti-tumor activity in heterotopic cancer animal model.
    Kim SD; Lee HY; Shim JW; Kim HJ; Baek SH; Zabel BA; Bae YS
    PLoS One; 2012; 7(1):e30522. PubMed ID: 22295090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.